Remiges Ventures Asset Manager Profile - aVenture Research
Remiges Ventures specializes in forming and managing innovative science-based companies, primarily focusing on the life sciences sector. The firm supports academic innovations, advancing portfolio companies from inception through Series A stage. Remiges typically invests in seed and Series A rounds, with occasional participation in Series B funding.
Notable portfolio companies include Cyrano Therapeutics, ENB Therapeutics, Glycomine, Immunis, Tranquis Therapeutics, and Viage Therapeutics. Remiges offers hands-on management during company formation, leveraging its team's expertise to guide product development. The firm's unique approach involves creating companies based on intellectual properties from Japanese academia and transforming them into viable commercial entities.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.